Business Standard

GVK Bio partners US firm

BS Reporter  |  Chennai 

Hyderabad-based drug discovery research and development firm (GVK Bio) has entered into a collaboration agreement with US-based Endo Pharmaceuticals focused on discovering novel small molecules targeting a protein.

As per the agreement, GVK Bio will use its discovery expertise to deliver a clinical candidate and Endo will develop and commercialise the product arising out of this collaboration. The collaboration arose out of a newly-launched concept at GVK Bio named Early Discovery Assets (EDA).

RECOMMENDED FOR YOU

GVK Bio partners US firm

Hyderabad-based drug discovery research and development firm GVK Biosciences (GVK Bio) has entered into a collaboration agreement with US-based Endo Pharmaceuticals focused on discovering novel small molecules targeting a protein.

Hyderabad-based drug discovery research and development firm (GVK Bio) has entered into a collaboration agreement with US-based Endo Pharmaceuticals focused on discovering novel small molecules targeting a protein.

As per the agreement, GVK Bio will use its discovery expertise to deliver a clinical candidate and Endo will develop and commercialise the product arising out of this collaboration. The collaboration arose out of a newly-launched concept at GVK Bio named Early Discovery Assets (EDA).

image
Widgets Magazine
Widgets Magazine
Widgets Magazine

Advertisement